Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 251-257, May 2009

Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease☆

☆☆Presented as part of the SUO/SBUR 2007 Annual Meeting, Anaheim, CA, May 2007. Program Director: Christopher Evans, M.D.

Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA

Received 8 February 2009; received in revised form 10 March 2009; accepted 10 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by a Career Development Award from the Prostate Cancer Foundation, a Damon Runyon-Genentech Clinical Investigator Award, and NIH grant 5K23 CA122820-02 (all to E.A.M.); and the NIH/NCI Pacific Northwest Prostate Cancer SPORE grant P50CA97186 (to P.S.N.).

PII: S1078-1439(09)00092-1

doi:10.1016/j.urolonc.2009.03.016

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 251-257, May 2009

Article Tools

* Image Usage & Resolution